Completed Clinical Trials

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

By April 24, 2017 No Comments


Malignant Mesothelioma

Estimated Enrollment: 30

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Primary Purpose: Treatment

Study ID Numbers: CDR0000066141|P30CA016087|NYU-9850|MDA-FDR001234|MDA-ID-95209|NCI-G99-1575

Study First Received: December 10, 1999

Last Updated: March 25, 2011

Estimated Primary Completion Date: May 2001


Primary Outcome Measures:

Sponsors and Collaborators:

New York University School of Medicine|National Cancer Institute (NCI)

Website Link:

Leave a Reply

Call Now